Nikhil Prasad Fact checked by:Thailand Medical News Team Feb 23, 2026 2 hours, 11 minutes ago
Medical News: New research uncovers mitochondrial DNA alterations that may serve as early warning signals
Parkinson’s disease remains one of the most challenging neurodegenerative disorders to diagnose early, largely because visible symptoms often appear only after significant brain damage has already occurred. Now, scientists have identified important chemical changes in mitochondrial DNA that may help explain how early-onset Parkinson’s disease develops and potentially open the door to future blood-based diagnostic tools. This
Medical News report examines the new findings in detail and explains why they could reshape how researchers view the disease at a molecular level.
Scientists identify mitochondrial DNA epigenetic changes in blood that may help detect early-onset Parkinson’s disease
Institutions behind the research
The study was conducted by researchers from the Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus, including the Neuroepidemiology Department, Cancer Genetics, Therapeutics and Ultrastructural Pathology Department, Biostatistics Unit, and Neuroimmunology Department, with additional collaboration from the Department of Psychology, University of Cyprus.
Understanding early-onset Parkinson’s disease
Parkinson’s disease affects movement, coordination, and several non-motor functions such as sleep, mood, and digestion. Early-onset Parkinson’s disease refers to patients diagnosed between the ages of 21 and 50 and represents a smaller but clinically important subset of cases. These patients often show slower disease progression but may have stronger links to genetic and mitochondrial factors.
Scientists have increasingly focused on mitochondria, the tiny structures inside cells responsible for producing energy. When mitochondrial function declines, nerve cells become vulnerable, which may contribute to the gradual degeneration seen in Parkinson’s disease.
What the researchers investigated
The research team analyzed blood samples from individuals with early-onset Parkinson’s disease and compared them with age- and sex-matched healthy controls. Rather than examining only selected regions, the scientists performed a comprehensive analysis of the entire mitochondrial genome, studying chemical modifications known as methylation and hydroxymethylation.
These chemical tags do not alter the DNA sequence itself but influence how genes function. By using advanced sequencing techniques capable of distinguishing true methylation from related modifications, the team created a detailed map of mitochondrial epigenetic changes at both global and single-base resolution.
Major findings revealed
The study showed that overall mitochondrial DNA methylation levels were significantly higher in early-onset Parkinson’s patients compared to controls. However, when researchers examined individual DNA positions, many specific sites displayed r
educed methylation, suggesting a complex redistribution of chemical marks rather than a simple increase.
A large proportion of the altered sites were found in genes involved in oxidative phosphorylation, the process that generates cellular energy. This supports long-standing theories that energy metabolism dysfunction plays a central role in Parkinson’s disease.
Another key observation involved the mitochondrial D-loop region, a critical control area responsible for regulating mitochondrial gene activity. Many sites in this region were found to be hypomethylated in patients, which may influence mitochondrial replication and transcription. Researchers also observed that non-CpG methylation patterns, often overlooked in earlier studies, were strongly represented, indicating that mitochondrial epigenetic regulation may be more complex than previously believed.
Why these findings matter
The possibility that blood samples could reveal molecular signatures linked to Parkinson’s disease is especially important. Current diagnosis relies heavily on clinical symptoms, which emerge late in the disease process. If validated in larger studies, mitochondrial DNA methylation patterns could eventually help identify patients earlier, monitor disease progression, or even guide future therapeutic strategies.
The study also reinforces the idea that Parkinson’s disease may involve epigenetic regulation, meaning environmental and biological factors could influence disease risk without altering the underlying genetic code.
Conclusions
The findings provide strong evidence that early-onset Parkinson’s disease is associated with widespread mitochondrial DNA epigenetic alterations detectable in blood. These changes appear concentrated in energy-related genes and regulatory regions, supporting the theory that mitochondrial dysfunction is a key driver of disease development. Although the research does not yet prove causation, it highlights promising biomarkers that may improve early detection and deepen understanding of disease mechanisms. Further large-scale studies integrating functional mitochondrial analysis will be essential to confirm how these epigenetic patterns influence disease onset and progression.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/4/2033
For the latest on Parkinson’s Disease, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/alzheimer,-dementia-
Share
Tweet
Share
